Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy
- PMID: 34048531
- PMCID: PMC8164145
- DOI: 10.1001/jamainternmed.2021.2959
Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy
Abstract
This cohort study examines the rate of SARS-CoV-2 reinfection among people in Lombardy, Italy, who previously recovered from COVID-19.
Conflict of interest statement
Figures
Comment in
-
Protection Because of Prior SARS-CoV-2 Infection.JAMA Intern Med. 2021 Oct 1;181(10):1409. doi: 10.1001/jamainternmed.2021.2966. JAMA Intern Med. 2021. PMID: 34048534 No abstract available.
-
Assessment of FDA Approval for New High-risk Therapeutic Devices Not Meeting Pivotal Study Primary End Points, 2016-2020.JAMA Intern Med. 2021 Oct 1;181(10):1409-1412. doi: 10.1001/jamainternmed.2021.3042. JAMA Intern Med. 2021. PMID: 34152383 Free PMC article.
References
-
- Hall VJ, Foulkes S, Charlett A, et al. ; SIREN Study Group . SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN). Lancet. 2021;397(10283):1459-1469. doi:10.1016/S0140-6736(21)00675-9 - DOI - PMC - PubMed
-
- Hansen CH, Michlmayr D, Gubbels SM, Mølbak K, Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021;397(10280):1204-1212. doi:10.1016/S0140-6736(21)00575-4 - DOI - PMC - PubMed
-
- US Centers for Disease Control and Prevention . Investigative criteria for suspected cases of SARS-CoV-2 reinfection (ICR). Accessed March 1, 2021. https://www.cdc.gov/coronavirus/2019-ncov/php/invest-criteria.html
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous